Login / Signup

Biosimilars Would Reduce Health Care Costs But Are Yet Poorly Known - Patient Survey Study Among Biological Medicine Users.

Mari PölkkiTuire Prami
Published in: Integrated pharmacy research & practice (2024)
Although the most recent treatments appear to be initiated with biosimilars, interchange in pharmacies could enable an efficient way to lower health care costs. However, guidance and awareness regarding biosimilars and biological medicines in general would improve patients' willingness towards the change, but also help pharmacists and prescribing doctors in their meaningful role.
Keyphrases
  • healthcare
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • peritoneal dialysis
  • emergency department
  • patient reported outcomes
  • health insurance
  • affordable care act